Immunology

Predicting whether bowel cancers will respond to immunotherapy

Scientists from the Francis Crick Institute and King's College London have studied colorectal cancer and found that levels of specific immune cells are the best predictors of whether immunotherapy will be effective in individual ...

Oncology & Cancer

Immunotherapy may be effective for some prostate cancers

In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors. Prostate ...

Medical research

Common tumor inhibitor drug triggers unfavorable immune effects

Cancer immunotherapy involving drugs that inhibit CTLA-4 also activates an unwanted response that may self-limit its efficacy in fighting tumors, according to a new study led by Francesco Marangoni, Ph.D., assistant professor ...

Oncology & Cancer

Study finds dosing strategy may affect immunotherapy outcomes

Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.

Oncology & Cancer

Combining immunotherapies against cancer

A new cancer vaccine could boost the positive effects of existing immunotherapy drugs, improving the success rate of treatments from 20% to 75% of cases, according to a new study by immunologists from the University of Konstanz. ...

page 20 from 40